Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

TerminatedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

January 18, 2023

Study Completion Date

January 18, 2023

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

Spiriva® Respimat®

DEVICE

Spiriva® HandiHaler®

DRUG

Tiotropium bromide

Trial Locations (1)

Cantonal Hosp. Baselland,Univ.Med.Dept,Liestal, Liestal